首页> 外文OA文献 >Increased Lipid Synthesis and Decreased β-Oxidation in the Liver of SHR/NDmcr-cp (cp/cp) Rats, an Animal Model of Metabolic Syndrome
【2h】

Increased Lipid Synthesis and Decreased β-Oxidation in the Liver of SHR/NDmcr-cp (cp/cp) Rats, an Animal Model of Metabolic Syndrome

机译:在ShR / NdMCR-CP(CP / CP)大鼠肝脏肝脏中增加脂质合成和β-氧化,代谢综合征的动物模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

SHR/NDmcr-cp (cp/cp) rats (SHR/NDcp) are an animal model of metabolic syndrome. A previous study of ours revealed drastic increases in the mass of palmitic (16:0), oleic (18:1n-9), palmitoleic (16:1n-7), cis-vaccenic (18:1n-7) and 5,8,11-eicosatrienoic acids in the liver of SHR/NDcp. However, detailed information on the class of lipid accumulated and the mechanism responsible for the overproduction of the accumulated lipid in the liver was not obtained. This study aimed to characterize the class of lipid accumulated and to explore the mechanism underlying the lipid accumulation in the liver of SHR/NDcp, in comparison with SHR/NDmcr-cp (+/+) (lean hypertensive littermates of SHR/NDcp) and Wistar Kyoto rats. In the liver of SHR/NDcp, de novo synthesis of fatty acids (16:0, 18:1n-9 and 16:1n-7) and triacylglycerol (TAG) synthesis were up-regulated and fatty acid β-oxidation was down-regulated. These perturbations of lipid metabolism caused fat accumulation in hepatocytes and accumulation of TAG, which were enriched with 16:0, 18:1n-9 and 16:1n-7, in the liver of SHR/NDcp. On the other hand, no changes were found in hepatic contents of diacylglycerol and unesterified fatty acid (FFA); among FFA, there were no differences in the hepatic concentrations of unesterified 16:0 and stearic acid between SHR/NDcp and two other groups of rats. Moreover, little change was brought about in the expression of genes responsive to endoplasmic reticulum stress in the liver of SHR/NDcp. These results may reinforce the pathophysiological role of stearoyl-CoA desaturase 1 and fatty acid elongase 6 in the liver of SHR/NDcp.
机译:SHR / NDMCR-CP(CP / CP)大鼠(SHR / NDCP)是代谢综合征的动物模型。先前对我们的研究表明,棕榈能(16:0),油酸(18:1N-9),棕榈药(16:1N-7),CIS-疫苗(18:1N-7)和5,在SHR / NDCP肝脏中的8,11-己二辛酸。然而,没有获得关于累积脂质类别的详细信息和负责肝脏中累积脂质的过度生产的机制。该研究旨在表征积累的脂质类,并探讨了SHR / NDCP肝脏肝脏脂质积累的机制,相当于SHR / NDMCR-CP(+ / +)(SHR / NDCP的贫血管凋落物)和Wistar Kyoto大鼠。在SHR / NDCP的肝脏中,脱脂酸的Novo合成(16:0,18:1N-9和16:1N-7)和三酰基甘油(标签)合成被上调,脂肪酸β-氧化下降 - 管制。这些脂质代谢的这些扰动导致肝细胞的脂肪积累和标签的积累,其在SHR / NDCP的肝脏中富含16:0,18:1N-9和16:1N-7。另一方面,在二酰基甘油和未酯化的脂肪酸(FFA)的肝含量中没有发现变化;在FFA中,肝脏浓度的肝脏浓度和21只大鼠两组大鼠之间的肝浓度和硬脂酸没有差异。此外,在响应于SHR / NDCP的肝脏中的内质网胁迫的基因表达中引起了几乎没有变化。这些结果可以增强硬脂酰-CoA去饱和酶1和脂肪酸连续酶6在SHR / NDCP的肝脏中的病理生理作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号